Brought to you by 
Spherics signs drug delivery deal with Ares-Serono
12 Jun 2000
Executive Summary
Spherics Inc. (drug delivery start-up) entered into an agreement with Ares-Serono to develop an oral formulation of an undisclosed Ares-Serono protein drug that is currently on the market in an injectable formulation.
Deal Industry
-
Pharmaceuticals
- Drug Delivery
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Spherics signs drug delivery deal with Ares-Serono
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice